Latest 5AM Venture Management, LLC Stock Portfolio
$447Million– No. of Holdings #28
5AM Venture Management, LLC Performance:
2024 Q2: -10.75%YTD: -1.17%2023: -15.69%
Performance for 2024 Q2 is -10.75%, and YTD is -1.17%, and 2023 is -15.69%.
About 5AM Venture Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, 5AM Venture Management, LLC reported an equity portfolio of $447.1 Millions as of 30 Jun, 2024.
The top stock holdings of 5AM Venture Management, LLC are SKYE, TRDA, . The fund has invested 18.2% of it's portfolio in SKYE BIOSCIENCE INC and 14.1% of portfolio in ENTRADA THERAPEUTICS INC.
The fund managers got completely rid off MERUS N V (MRUS), AVIDITY BIOSCIENCES INC (RNA) and CIDARA THERAPEUTICS INC (CDTX) stocks. They significantly reduced their stock positions in ENLIVEN THERAPEUTICS INC. 5AM Venture Management, LLC opened new stock positions in SKYE BIOSCIENCE INC (SKYE), ERASCA INC (ERAS) and TECTONIC THERAPEUTIC INC. The fund showed a lot of confidence in some stocks as they added substantially to BIOHAVEN LTD.
The top stock holdings of 5AM Venture Management, LLC are SKYE, TRDA, . The fund has invested 18.2% of it's portfolio in SKYE BIOSCIENCE INC and 14.1% of portfolio in ENTRADA THERAPEUTICS INC.
The fund managers got completely rid off MERUS N V (MRUS), AVIDITY BIOSCIENCES INC (RNA) and CIDARA THERAPEUTICS INC (CDTX) stocks. They significantly reduced their stock positions in ENLIVEN THERAPEUTICS INC. 5AM Venture Management, LLC opened new stock positions in SKYE BIOSCIENCE INC (SKYE), ERASCA INC (ERAS) and TECTONIC THERAPEUTIC INC. The fund showed a lot of confidence in some stocks as they added substantially to BIOHAVEN LTD.
5AM Venture Management, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
5AM Venture Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that 5AM Venture Management, LLC made a return of -10.75% in the last quarter. In trailing 12 months, it's portfolio return was -6.74%.
New Buys
| Ticker | $ Bought |
|---|---|
| skye bioscience inc | 81,537,800 |
| erasca inc | 12,756,800 |
| tectonic therapeutic inc | 10,648,200 |
| cidara therapeutics inc | 677,297 |
| eyepoint pharmaceuticals inc | 435,000 |
New stocks bought by 5AM Venture Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| biohaven ltd | 46.88 |
Additions to existing portfolio by 5AM Venture Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| enliven therapeutics inc | -31.94 |
| dianthus therapeutics inc | -0.73 |
5AM Venture Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avidity biosciences inc | -16,985,000 |
| merus n v | -24,713,600 |
| cidara therapeutics inc | -1,043,750 |
5AM Venture Management, LLC got rid off the above stocks
Sector Distribution
5AM Venture Management, LLC has about 52.9% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 52.9 |
| Healthcare | 47.1 |
Market Cap. Distribution
5AM Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 52.9 |
| SMALL-CAP | 31.7 |
| MID-CAP | 9.7 |
| MICRO-CAP | 5.7 |
Stocks belong to which Index?
About 37.6% of the stocks held by 5AM Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 62.4 |
| RUSSELL 2000 | 37.6 |
5AM Venture Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of 5AM Venture Management, LLC
5AM Venture Management, LLC has 28 stocks in it's portfolio. About 73.5% of the portfolio is in top 10 stocks. VOR proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for 5AM Venture Management, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADVM | adverum biotechnologies inc | 0.83 | 541,666 | 3,715,830 | unchanged | 0.00 | ||
| ANAB | anaptysbio inc | 2.00 | 357,733 | 8,964,790 | unchanged | 0.00 | ||
| CDTX | cidara therapeutics inc | 0.15 | 56,725 | 677,297 | new | |||
| CDTX | cidara therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 4.12 | 497,270 | 18,404,000 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 2.52 | 1,245,000 | 11,242,400 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 1.49 | 790,440 | 6,663,410 | unchanged | 0.00 | ||
| ERAS | erasca inc | 2.85 | 5,405,400 | 12,756,800 | new | |||
| EYPT | eyepoint pharmaceuticals inc | 0.10 | 50,000 | 435,000 | new | |||
| MLTX | moonlake immunotherapeutics | 2.78 | 282,313 | 12,413,300 | unchanged | 0.00 | ||
| MRSN | mersana therapeutics inc | 0.59 | 1,305,000 | 2,623,050 | unchanged | 0.00 | ||
| MRUS | merus n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PHVS | pharvaris n v | 3.35 | 797,600 | 14,994,900 | unchanged | 0.00 | ||
| PRAX | praxis precision medicines i | 3.14 | 340,000 | 14,062,400 | unchanged | 0.00 | ||
| RLYB | rallybio corp | 1.09 | 3,630,720 | 4,865,170 | unchanged | 0.00 | ||
| RNA | avidity biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SCPH | scpharmaceuticals inc | 1.17 | 1,200,650 | 5,222,810 | unchanged | 0.00 | ||
| SKYE | skye bioscience inc | 18.24 | 10,179,500 | 81,537,800 | new | |||
| TRDA | entrada therapeutics inc | 14.05 | 4,408,380 | 62,819,400 | unchanged | 0.00 | ||
| TYRA | tyra biosciences inc | 3.36 | 939,298 | 15,019,400 | unchanged | 0.00 | ||